Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes
A legfontosabb adatok
- Ki végzi
- M.D. Anderson Cancer Center
- Hol
- Houston (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 169 fő vett részt
- Kezdés
- 2022. jún. 2.
- Befejezés
- 2026. jan. 7.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Nicotine Replacement
- Questionnaire Administration
- Electronic Cigarette
- A regiszteradat frissítve
- 2026. január 28.
Ki vehet részt
- Életkor
- 21 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 14 feltétel megnézéseKevesebb
Ki vehet részt
- Aged 21 years or older
- Reports being a daily or non-daily smoker (any self-reported smoking in the past 30 days)
- Have an address where he/she can receive mail
- Able to follow verbal and written instructions in English and complete all aspects of the study as determined by PI
- Willing to have urine biospecimen samples taken, either in-home and returning them by mail, or in-person at an approved collection site
- Willing to use tobacco-flavored study electronic cigarettes
- Agrees to comply with all MD Anderson institutional policies related to COVID-19 screening prior to any in-person research visit
- The individual agrees to not engage in study procedures or interactions with study personnel while operating a vehicle
Ki nem vehet részt
- Being pregnant, engaging in breast-feeding, or being of childbearing potential and engaging in sexual activity that could lead to pregnancy and is not protected by a medically acceptable, effective method of birth control while enrolled in the study, as determined by self-report. Medically acceptable contraceptives include: (1) approved hormonal contraceptives (such as birth control pills, patches, implants or injections), (2) barrier methods (such as a condom or diaphragm) used with a spermicide, or (3) an intrauterine device (IUD). Contraceptive measures sold for emergency use after unprotected sex are not acceptable methods for routine use
- Uncontrolled or unstable medical condition (e.g., uncontrolled hypertension, angina, diabetes)
- Individuals who report depressive symptoms in the moderately severe or severe range on the PHQ-9 (scores of 15 or above) or who report current suicidal ideation on the PHQ-9
- Evidence of cognitive deficits or instability that would preclude reliable study participation
- Considered by the investigator to be an unsuitable or unstable candidate (including but not limited to the following situation: unwilling or unable to comply with study procedures)
- Individuals who reside in an area that is outside of our shipping company's area of operation or in a jurisdiction outside of our medical staff's licensure (if unable to attend in-person clinic visits) AND who decline or are unable to come in to clinic to provide necessary samples and/or collect study products
Helyszínek itt: Egyesült Államok
- M D Anderson Cancer CenterHouston, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This early phase I trial studies potential differences between men and women when switching from the use of combustible cigarettes to the National Institute on Drug Abuse's Standard Research E-Cigarette (SREC). Studying the differences between men and women may increase understanding about the effects of switching from smoking regular cigarettes to electronic cigarettes.
A vizsgálat 2 csoportja
- E-Cig placebo dose followed by E-Cig nicotine doseA vizsgált kezelés
Participants will be instructed to smoke their usual brand cigarette as they normally would in weeks 1-2 (Phase I) and to use only the SREC (with or without nicotine) in weeks 3-4 (Phase II) and in weeks 5-6 (Phase III). Participant assignment to SREC type at Phases II and III will be counter-balanced within group, with half of men and women receiving the placebo SREC during Phase II and half during Phase III. Participants will attend 4 laboratory visits with study investigators for 3 hours each over 6 weeks of study participation.
Kezelés: Nicotine Replacement, Questionnaire Administration és Electronic Cigarette
- E-Cig nicotine dose followed by E-Cig placebo doseA vizsgált kezelés
Participants will be instructed to smoke their usual brand cigarette as they normally would in weeks 1-2 (Phase I) and to use only the SREC (with or without nicotine) in weeks 3-4 (Phase II) and in weeks 5-6 (Phase III). Participant assignment to SREC type at Phases II and III will be counter-balanced within group, with half of men and women receiving the placebo SREC during Phase II and half during Phase III. Participants will attend 4 laboratory visits with study investigators for 3 hours each over 6 weeks of study participation.
Kezelés: Nicotine Replacement, Questionnaire Administration és Electronic Cigarette
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Gender Differences in Standardized Research E-Cigarette (SREC) Product Use, Acceptability, Reinforcement, and Nicotine Dependence Symptoms
- Publikációk
- Standardized research electronic cigarette acceptability among adult men and women who smoke combustible cigarettes.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2025
- A regiszteradat frissítve
- 2026. január 28.